
Pharma Fridays – May 2, 2025
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * On April 30, Amylyx Pharmaceuticals, Inc. announced that the first participant has been dosed in the pivotal Phase 3 LUCIDITY clinical trial of avexitide …